Navigation Links


Access at Biology News

BioMed Central welcomes the new National Institutes of Health public access policy

BioMed Central welcomes the announcement of the US National Institutes of Health (NIH) new public access policy. The NIH calls on all of i...

Not-for-profit publishers call NIH public access rule a missed opportunity

The final National Institutes of Health (NIH) rule on Enhanced Public Access to NIH Research Information is wasteful of federal research dollars and a missed opportunity to take advantage of...

Open Access journals get impressive impact factors

Impressive impact factors prove that BioMed Central's Open Access journals are high quality and widely read and cited. Journals published by BioMed Central have again received impact factors that compare well with equivalent subscription titles, it was announced today, with five titles in the top five of their specialty. The high impact factors for these journals affirm that they are respected by...

Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity

The single most important issue obstructing the productivity of biomedical scientists today is the culture of research funding. This finding challenges the belief of some that the lack of "open access" to journal content is a major barrier to scientific productivity. A survey of 883 biomedical scientists ?in Europe and North America - commissioned by the Publishing Research Consortium fo...

Access to existing medical treatments could save more lives than spending to improve the treatments

More lives could be saved in the United States by spending less money on making medical treatments better and more on getting existing treatments to the patients who need them, according to a study published by a Virginia Commonwealth University family medicine and public health physician. "For every dollar Congress gives the National Institutes of Health to develop blockbuster treatments,...

More>>

Access at Biology Products

Multisignal Output Accessory from Agilent Technologies

Description:Agilents G1979A multisignal output accessory lessens the expensive task of validating multiple data systems in laboratories with multiple mass spectrometers. It converts the unprocessed digital MS signals from Agilent 1100 Series LC/MSD quadrupole mass spectrometers into analog format and transmits the analog data directly to a laboratory information management (LIMS) systems for processing. Calc...
Company:Agilent Technologies

GR4 Auto Access 100V/50-60Hz from Thermo Scientific

Description:Automated centrifuge for the processing of microplates and tubes; can be integrated into automated process using inexpensive robotics due to its unique sample handling platform....
Company:Thermo Scientific

Top and Front Access CryoMed Freezer, LN2, Integrated Control and 4" Printer, IVF, 1.2 cu ft, 120V, 60 Hz from Thermo Scientific

Description:Thermo Electron's CryoMed Freezers for IVF are designed for human in vitro fertiliaztion (K021042) with precise control, ease of setup and operation, and convenience. Chamber, sample temperature and operation status are continuously displayed on the control panel. Our signature graph and the cycle data are printed by way of the thermal printer inside the top of unit. These IVF models provide con...
Company:Thermo Scientific

Uniblot accessories from Sigma-Aldrich

Description:lid holder for more info...
Company:Sigma-Aldrich

Uniblot accessories from Sigma-Aldrich

Description:BlotGel application pool for more info...
Company:Sigma-Aldrich

More>>

Access at Biology Technology

Governor Doyle Plans To Increase Web Access

MADISON, WI Governor Jim Doyle today announced his "Grow Wisconsin" initiative to drive state economic development. One of the recommendations is to increase broadband and communications access for all residents in the state. Mike Tye, AT&T regional vice present of Law and Government Affairs, commented that AT&T is encouraged by the "Grow Wisconsin" initiative unveiled today by Wisconsin...

Research explains why women lack equal access to angel capital

The research, conducted by Jeffrey Sohl, director of the at the University of New Hampshire, examined the equa...

Abbott vs. Thailand has implications for innovation and access

story regarding its Kaletra AIDS drug and the conflict with the government of Thailand over patent protection and drug pricing. Some of you may regard this as a relatively isolated tiff between a single drug company and another developing country. Others consider this to be a...

More access points for Madison wireless

Now, , which provides wireless Internet service in a 10-block radius of Madison's Capitol Square a...

GE partner allows real-time access to patient data

technology that, when combined with an accompanying software application, allows obstetricians to remotely monitor the real-time condition of mothers and fetuses, and obtain other data from its...

More>>

Access at Medicine News

Controversial deal on public access of the human genome map

, which is a much talked about topic, considering that the mapping of the genes will enable one to have the information to manipulate individual characteristics like the color of the eye or even skin. It will also help say whether a cell will function normall...

Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.

In Vancouver Health Canada gives access to the usage of two drugs in a rare medical trail. These drugs were necessary to help prevent men dying of AIDS. // They are anti-retroviral drugs which have been studied individually but there action together is not been reviewed. These drugs are unapproved for the usage in AIDS patient and hence their access is declined by the government. <br...

Health Care Disparities cause of inaccessibility to new technology

Researchers feel that health care disparities occurs in the use of new technology for disease treatment between minorities and children’s, which make them not accessible to new technology and treatments in health care//. Researchers from Massachusetts General Hospital have reported that Health care disparities is found in minority and children’s affected with asthma and they are less like...

Scots Do Not Have Access To Proper Dental Care

An investigation conducted by the Scotsman has revealed that as many as 250,000 Scots are unable to access emergency dental care, particularly during weekends. // The Scottish Executive's Health Department had drawn up an emergency care plan which is yet to be implemented by the NHS. As much as £1.5 million has been allocated for this. The situation is reported to particularly bad in the country’...

Children In Scotland Denied Access To Dental Care

The free dental services rendered to Scotland children, could soon come to an end, warn Dentists, who are unhappy about the allowances, handed out by ministers. // Dental practices in Scotland yield a considerable amount of additional revenue , provided there are enough number of registered NHS patients. There exists a flaw in the definition of who would be eligible for such extra pay...

More>>

Access at Medicine Products

Access Immunoassay System

Description:The Access immunoassay system is a powerful random access benchtop analyzer that performs a variety of assays, with panels that include anemia, cardiovascular, reproductive, thyroid, infectious disease, blood virus, skeletal, tumor markers and specialty....
Company:Beckman Coulter, Inc.

Access 2 Immunoassay System

Description:With an intuitive operator interface, enhanced sample handling and innovative menu, the state-of-the-art Access 2 system delivers new levels of laboratory efficiency, standardization and cost effectiveness....
Company:Beckman Coulter, Inc.

Access Dilation Port

Description:The Access Dilation Port enables the surgeon to perform a traditional microdiscectomy utilizing a minimally invasive approach using step dilation. Using a series of dilators, soft tissue is gently pushed aside, creating space for a custom-sized working surgical port. The surgical port allows the surgeon to operate with a traditional surgical technique by providing a working channel thats appropri...
Company:Abbott Spine

PINNACLE Introducer Sheath Designed for Vascular Access

Description:Introducer Sheath Designed for Vascular Access...
Company:Boston Scientific Corporation

FLEXOR CHECK-FLO Introducer Sets for Radial Artery Access with AQ Hydrophylic Coating

Description:Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Company:Cook Incorporated

More>>

Access at Medicine Technology

PromegaExpress Expands Easy Access to Products with New Cabinet

MADISON, Wis.--(BUSINESS WIRE)--Jun 21, 2007 - ThePromegaExpress(TM) on-site stocking program just added a newlysized ambient cabinet to its line of on-site appliances. Thislatest addition serves as great option to meet individual labinventory requirements for smaller areas when space is at a premiumbut immediate access to life science tools is a necessity. Themid-sized cabinet can also be...

Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference

Pre-clinical Data Suggests Angiolix Can Inhibit Breast CancerGrowth By 75% DALLAS and IRVINE, Calif., June 04, 2007 /PRNewswire-FirstCall/-- Access Pharmaceuticals, Inc. (Bulletin Board: ACCP) and SomantaPharmaceuticals, Inc. (Bulletin Board: SMPM) announced today that ascientific abstract outlining new preclinical efficacy data forSomanta's Angiolix has been selected for publication in t...

Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting

DALLAS, April 16, 2007 /PRNewswire-FirstCall/ -- ACCESSPHARMACEUTICALS, INC. announced today that results of studies ofthe mechanism of ProLindac's anticancer activity will be presentedtoday at the American Association for Cancer Research (AACR) 2007annual meeting in Los Angeles at the Los Angeles Convention Center.The two poster presentations describe preclinical studies performedby Acc...
Other TagsWesternWesternWesternWesternWestern
(Date:10/11/2008)... Barnett International, a... has announced the release of The Form FDA 1572: A...s, and Monitors. Designed for clinical investigato...y affairs professionals, and others involved in th... reference guide to address the Form FDA 1572-Stat...
(Date:10/10/2008)... PACO Communications Named Agency ...gian American Hospital has just,announced the laun...signed,to build awareness of its long-standing com... and care through its Labor and Delivery, Special ... rolled out in Chicago with a focus on public rela...
(Date:10/10/2008)...1 in 6 likely to develop some form of disease by 2...FRIDAY, Oct. 10 (HealthDay News) -- Liver transpla... the general population, say researchers in Finlan...ssue of Liver Transplantation , researchers inves...er transplant recipients from Helsinki University ...
(Date:10/10/2008)... MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/...unces that it has appointed William,(Bill) Federic...ard to five,members., Mr. Federici joined West Ph...Financial Officer in August of 2003. Under his fin...have grown to more than $1.0 billion from,$300 mil...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 2Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3
(Date:10/10/2008)...Haven, Conn. Yale scientists have created nanowir...ronics that are both sensitive and specific enough...ion, according to a report in Nano Letters . , ...ly specific antigens signatures of bacteria, viru... are activated, they produce acid, and generate a ...
(Date:10/9/2008)...NTA CLARA, Calif., Oct. 9 /PRNewswire-FirstCall/ -...ading developer of human interface,solutions for m... devices,announced today that it will report fina... on Thursday, October 23, 2008 after the close of ...erence call for analysts and,investors at 2:00 p.m...
(Date:10/9/2008)...It,s hard being a mussel: you have to worry about ...ention an environment that can change your body te...s. , "It,s one of the most variable habitats on ... can spend part of the day bathed in cool Pacific ...rnia sun." , Gracey led the first real-time mole...
(Date:10/9/2008)...National Institute of Allergy and Infectious Disea...alth (NIH), will award five-year contracts estimat... in Systems Biology for Infectious Disease Researc...h facility will apply novel techniques to study di...ome (SARS), tuberculosis and influenza. , System...
Breaking Biology News(10 mins):Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3New Systems Biology Awards enable detailed study of microbes 2Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 1Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 2Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 1Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 2Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 1Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 1Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 7
Other Contentsabortionabortionabortionabortioninevitableinevitableinevitableinevitablereflexesreflexesreflexesdistressdistressdistressbotulismbotulismbotulisminfarctinfarctinfarctinfantsinfantsinfantsinfantsinfantsinfantsinfantileinfantile